~~<i id='813649E14B'><strike id='813649E14B'><tt id='813649E14B'><pre id='813649E14B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：focus 2025-09-30 00:47:48 - browse：952

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Long Covid research funding gets a major boost from NIH

explore

entertainment

hotspot

leisure time

entertainment

explore

BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB

WSS

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Medicare Advantage plans can’t deny care with AI, CMS warns

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Bernie brings in new pharma CEOs to talk drug prices

Artificial intelligence use in health care faces greater scrutiny in 2024

hotspot

entertainment

explore

Hepatitis C has a cure — but many Americans still lack access to it

Readout LOUD: Venture capital, Gilead, and more M&A

Tori Bowie and the unacceptable rates of Black maternal death

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Activists slam private health insurers over coverage restrictions

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Wildfire smoke exposes gaps in outdoor worker protections

Long Covid research funding gets a major boost from NIH

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ebola vaccine can save some who are already sick, per new study

entertainment

Devoted Health’s losses in Medicare Advantage persist

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Congress might make insulin pumps more accessible to the blind

Abbott's new heart device gets FDA advisory panel nod

Tome Biosciences co

Tome Biosciences co

hotspot

leisure time

entertainment

explore